Loveikyte R, Boer M, van der Meulen CN, Ter Steege RWF, Tack G, Kuyvenhoven J, Jharap B, Vu MK, Vogelaar L, West RL, van der Marel S, Römkens TEH, Mujagic Z, Hoentjen F, van Bodegraven AA, van Schaik FDM, de Vries AC, Dijkstra G, van der Meulen-de Jong AE; Dutch Initiative on Crohn and Colitis (ICC).J Clin Med. 2022 Nov 19;11(22):6843. doi: 10.3390/jcm11226843. Free PMC article.
Publicaties uit 2022
Prophylactic medication for the prevention of endoscopic recurrence in Crohn’s disease: a prospective study based on clinical risk stratification
Jeanine H C Arkenbosch, Evelien M J Beelen, Gerard Dijkstra, Mariëlle Romberg-Camps, Marjolijn Duijvestein, Frank Hoentjen, Sander van der Marel, P W Jeroen Maljaars, Sita Jansen, Nanne K H de Boer, Rachel L West, Carmen S Horjus, Laurents P S Stassen, Fiona D M van Schaik, Oddeke van Ruler, Bindia J H Jharap, Marijn Visschedijk, Alfred Janssen, Nicole S Erler, Michail Doukas, Ariadne H A G Ooms, Gursah Kats-Ugurlu, C Janneke van der Woude, Annemarie C de Vries, Dutch Initiative on Crohn’s and Colitis (ICC)
J Crohns Colitis. 2022 Sep 12;jjac128. doi: 10.1093/ecco-jcc/jjac128. Online ahead of print.
Subcutaneous administration, higher age and lower renal function are associated with erythrocyte methotrexate accumulation in Crohn’s disease: a cross-sectional study
M M van de Meeberg, M L Seinen, H H Fidder, M Lin, B Oldenburg, N K de Boer, G Bouma, R de Jonge, M Bulatović Ćalasan, Dutch Initiative on Crohn and Colitis (ICC)
BMC Gastroenterol. 2022 Jul 30;22(1):365. doi: 10.1186/s12876-022-02439-y.
Real-world experience of switching from intravenous to subcutaneous vedolizumab maintenance treatment for inflammatory bowel diseases
Adriaan Volkers, Tessa Straatmijer, Marjolijn Duijvestein, Amber Sales, Amit Levran, Fiona van Schaik, Jeroen Maljaars, Krisztina Gecse, Cyriel Ponsioen, Joep Grootjans, Jurij Hanzel, Greetje Tack, Jeroen Jansen, Frank Hoentjen, Nanne de Boer, Sander van der Marel, Gerard Dijkstra, Bas Oldenburg, Mark Löwenberg, Andrea van der Meulen, Geert D Haens, IBD center Amsterdam and the Dutch Initiative on Crohn and Colitis
Aliment Pharmacol Ther. 2022 Sep;56(6):1044-1054. doi: 10.1111/apt.17153. Epub 2022 Jul 23.
Superior Effectiveness of Tofacitinib Compared to Vedolizumab in Anti-TNF-experienced Ulcerative Colitis Patients: A Nationwide Dutch Registry Study
Tessa Straatmijer, Vince BC Biemans, Marijn Visschedijk, Frank Hoentjen, Annemarie de Vries, Adriaan A van Bodegraven, Alexander Bodelier, Nanne KH de Boer, Gerard Dijkstra, Noortje Festen, Carmen Horjus, Jeroen M Jansen, Bindia Jharap, Wout Mares, Fiona DM van Schaik, Cyriel Ponsioen, Tessa Romkens, Nidhi Srivastava, Michael MPJA van der Voorn, Rachel West, Janneke van der Woude, Marije DJ Wolvers, Marieke Pierik, Andrea E van der Meulen-de Jong, Marjolijn Duijvestein, Initiative on Crohn and Colitis (ICC)
Clin Gastroenterol Hepatol. 2022 May 26;S1542-3565(22)00510-9. doi: 10.1016/j.cgh.2022.04.038. Online ahead of print.
The launch of an online national multidisciplinary expert panel for inflammatory bowel disease
Nanne K de Boer, Florine L van Lookeren, Greetje J Tack, Dutch Initiative on Crohn and Colitis (ICC)
J Crohns Colitis. 2022 Jan 6;jjac002. doi: 10.1093/ecco-jcc/jjac002. Online ahead of print